Sporadic brain arteriovenous malformation (BAVM) is a tangled vascular lesion characterized by direct artery-to-vein connections that can cause life-threatening intracerebral hemorrhage (ICH). Recently, somatic mutations in KRAS have been reported in sporadic BAVM, and mutations in other mitogen-activated protein kinase (MAPK) signaling pathway genes have been identified in other vascular malformations. The objectives of this study were to systematically evaluate somatic mutations in MAPK pathway genes in patients with sporadic BAVM lesions and to evaluate the association of somatic mutations with phenotypes of sporadic BAVM severity.
The authors performed whole-exome sequencing on paired lesion and blood DNA samples from 14 patients with sporadic BAVM, and 295 genes in the MAPK signaling pathway were evaluated to identify genes with somatic mutations in multiple patients with BAVM. Digital droplet polymerase chain reaction was used to validate KRAS G12V and G12D mutations and to assay an additional 56 BAVM samples.
The authors identified a total of 24 candidate BAVM-associated somatic variants in 11 MAPK pathway genes. The previously identified KRAS G12V and G12D mutations were the only recurrent mutations. Overall, somatic KRAS G12V was present in 14.5% of BAVM lesions and G12D was present in 31.9%. The authors did not detect a significant association between the presence or allelic burden of KRAS mutation and three BAVM phenotypes: lesion size (maximum diameter), age at diagnosis, and age at ICH.
The authors confirmed the high prevalence of somatic KRAS mutations in sporadic BAVM lesions and identified several candidate somatic variants in other MAPK pathway genes. These somatic variants may contribute to understanding of the etiology of sporadic BAVM and the clinical characteristics of patients with this condition.
BAVM = brain arteriovenous malformation; ddPCR = digital droplet polymerase chain reaction; GATK = Genome Analysis Toolkit; ICH = intracerebral hemorrhage; MAPK = mitogen-activated protein kinase; OCT = optimal cutting temperature; PI = proportional increase; SNV = single-nucleotide variant; TLOD = theta logarithm of the odds; UCSF = University of California, San Francisco; WES = whole-exome sequencing.
RutledgeWC, AblaAA, NelsonJ, Treatment and outcomes of ARUBA-eligible patients with unruptured brain arteriovenous malformations at a single institution. Neurosurg Focus. 2014;37(3):E8.10.3171/2014.7.FOCUS14242)| false
MacmurdoCF, Wooderchak-DonahueW, Bayrak-ToydemirP, et al.RASA1 somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndrome. Am J Med Genet A. 2016;170(6):1450–1454.
MacmurdoCF, Wooderchak-DonahueW, Bayrak-ToydemirP, RASA1 somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndrome. Am J Med Genet A. 2016;170(6):1450–1454.10.1002/ajmg.a.3761326969842)| false
AkersAL, JohnsonE, SteinbergGK, et al.Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet. 2009;18(5):919–930.
PriemerDS, VortmeyerAO, ZhangS, Activating KRAS mutations in arteriovenous malformations of the brain: frequency and clinicopathologic correlation. Hum Pathol. 2019;89:33–39.10.1016/j.humpath.2019.04.00431026472)| false
CingolaniP, PlattsA, WangLL, et al.A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012;6(2):80–92.
CingolaniP, PlattsA, WangLL, A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012;6(2):80–92.10.4161/fly.19695)| false
WangQ, ShashikantCS, JensenM, Novel metrics to measure coverage in whole exome sequencing datasets reveal local and global non-uniformity. Sci Rep. 2017;7(1):885.2840874610.1038/s41598-017-01005-x)| false
ZhangY, IngramDA, MurphyMP, et al.Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am J Physiol Heart Circ Physiol. 2009;296(5):H1675–H1682.
ZhangY, IngramDA, MurphyMP, Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am J Physiol Heart Circ Physiol. 2009;296(5):H1675–H1682.10.1152/ajpheart.00665.200819252096)| false
WinklerEA, BellRD, ZlokovicBV. Pericyte-specific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta receptor signaling. Mol Neurodegener. 2010;5:32.2073886610.1186/1750-1326-5-32)| false
CheungHW, DuJ, BoehmJS, et al.Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers. Cancer Discov. 2011;1(7):608–625.
CheungHW, DuJ, BoehmJS, Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers. Cancer Discov. 2011;1(7):608–625.2258668310.1158/2159-8290.CD-11-0046)| false
SunZ, LawsonDA, SinclairE, et al.Endovascular biopsy: strategy for analyzing gene expression profiles of individual endothelial cells obtained from human vessels. Biotechnol Rep (Amst). 2015;7:157–165.